JonesTrading Downgrades Concert Pharma to Hold
JonesTrading analyst Sean Kim downgrades Concert Pharma (NASDAQ:CNCE) from Buy to Hold.
OTR Global Downgrades VF to Negative
OTR Global downgrades VF (NYSE:VFC) from Mixed to Negative.
Gordon Haskett Downgrades Nordstrom to Reduce, Lowers Price Target to $13
Gordon Haskett analyst Chuck Grom downgrades Nordstrom (NYSE:JWN) from Hold to Reduce and lowers the price target from $20 to $13.
JMP Securities Downgrades Innovative Ind Props to Market Perform
JMP Securities analyst Aaron Hecht downgrades Innovative Ind Props (NYSE:IIPR) from Market Outperform to Market Perform.
Cowen & Co. Downgrades Salesforce to Market Perform
Cowen & Co. analyst Derrick Wood downgrades Salesforce (NYSE:CRM) from Outperform to Market Perform.
MKM Partners Downgrades Pinterest to Neutral, Announces $27 Price Target
MKM Partners analyst Rohit Kulkarni downgrades Pinterest (NYSE:PINS) from Buy to Neutral and announces $27 price target.
Jefferies Downgrades LCI Indus to Hold, Lowers Price Target to $95
Jefferies analyst Bret Jordan downgrades LCI Indus (NYSE:LCII) from Buy to Hold and lowers the price target from $120 to $95.
JP Morgan Downgrades Cyteir Therapeutics to Neutral
JP Morgan analyst Anupam Rama downgrades Cyteir Therapeutics (NASDAQ:CYT) from Overweight to Neutral.
Keybanc Downgrades Riskified to Sector Weight
Keybanc analyst Josh Beck downgrades Riskified (NYSE:RSKD) from Overweight to Sector Weight.
Charles Schwab Faces Double Downgrade Reflecting Client Cash Sorting & End To Fed Rate Hike
BofA Securities analyst Craig Siegenthaler downgraded Charles Schwab Corp (NYSE:SCHW) from Buy to Underperform and lowered the price target from $92 to…